Art

J-GLOBAL ID：201902244641191496   Reference number：19A2230576

A phase II study of the combination of docetaxel and bevacizumab for previously treated non-small cell lung cancer

以前に治療された非小細胞肺癌に対するドセタキセルとベバシズマブの併用の第II相試験【JST・京大機械翻訳】

Author (6)： Shimizu Tetsuo (Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan) ,  Nakagawa Yoshiko (Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan) ,  Asai Yasuo (Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan) ,  Tsujino Ichirou (Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan) ,  Takahashi Noriaki (Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan) ,  Gon Yasuhiro (Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan)
Material： Journal of International Medical Research  (J Int Med Res)
Volume： 47  Issue： 7  Page： 3079-3087  Publication year： 2019 
JST Material Number： T0238A  ISSN： 1473-2300  CODEN： JIMRBV  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Abstract/Point： Objective: The standard therap...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A2230576&from=J-GLOBAL&jstjournalNo=T0238A") }}

Thesaurus term： antitumor drug ,  human(primates) ,  effectiveness ,  neutropenia ,  antibody ,  antitumor action ,  *phase 2 study ,  drug therapy ,  *therapy ,  *non-small cell lung cancer ,  aromatic carboxylic acid ,  carbamate ,  oxygen heterocyclic compound ,  bridged compound ,  tetracyclic diterpene ,  carboxylate(ester) ,  hydroxy acid ,  hydroxy ketone ,  polyol
Semi thesaurus term： レジメン ,  有害事象 ,  疾患進行 ,  進行非小細胞肺癌 ,  *ベバシズマブ , 【Automatic Indexing@JST】

Author keywords (6)： Docetaxel ,  bevacizumab ,  advanced non-squamous non-small cell lung cancer ,  adverse events ,  chemotherapy ,  disease recurrence

JST classification (2)： Tumors(=neoplasms)of respiratory system  (GI04000G) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Substance index (1)： Docetaxel

Terms in the title (6)： 治療 ,  非小細胞肺癌 ,  ドセタキセル ,  ベバシズマブ ,  併用 ,  第II相試験